Nemluvio 30 MG pens
Ended Awarded Last action
- Contract number
- SPE2DR26F1Y23
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,033
Award facts
- Contract value 100% obligated
- $2,033.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,033.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens on January 28, 2026, with an ultimate completion date of February 19, 2026. This is a child contract with no set-aside designation, competitively awarded under the company's existing indefinite delivery contract with DLA Troop Support Medical. The work will be performed in Conshohocken, Pennsylvania, the location of the awardee's corporate office. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor that serves as a critical vendor for federal military and veteran healthcare systems.
This delivery order represents a routine pharmaceutical supply transaction within AmerisourceBergen's broader $999.99 billion indefinite delivery contract vehicle with DLA Troop Support Medical, which extends through December 2026 and supports military healthcare programs globally. Nemluvio, a specialty medication used in oncology treatment, is among the comprehensive range of brand-name and generic pharmaceuticals, vaccines, and medical supplies the contractor delivers through this prime vendor agreement. The contract award demonstrates the contractor's established capability to fulfill federal medical procurement requirements efficiently under firm fixed-price arrangements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F1Y23?
SPE2DR26F1Y23 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F1Y23 worth?
The government has obligated $2,033 on SPE2DR26F1Y23.
Is contract SPE2DR26F1Y23 an order under another contract?
Yes. SPE2DR26F1Y23 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1Y23 competed?
The extent of competition for SPE2DR26F1Y23 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award